First US Johnson & Johnson vaccine doses ship Sunday night, Missouri getting 50,000

News

An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Johnson & Johnson on November 17, 2020. (Photo by JUSTIN TALLIS / AFP) (Photo by JUSTIN TALLIS/AFP via Getty Images)

WASHINGTON — Nearly 4 million doses of the newest COVID-19 vaccine were shipped Sunday night. They will begin to be delivered to states for injections starting on Tuesday.

White House COVID-19 coordinator Jeff Zients announced that the entire stockpile of the newly approved single-dose Johnson & Johnson vaccine will go out immediately. J&J will deliver about 16 million more doses by the end of March and 100 million total by the end of June.

The Missouri Department of Health and Senior Services said on Sunday the state is set to receive 50,000 doses of the third approved COVID-19 vaccine this week.

“We are incredibly appreciative to be receiving additional vaccines in Missouri, and we remain committed to making it available for a variety of vaccinators to get it into arms as efficiently as possible,” Dr. Randall Williams stated in a release.

“The order issued today will authorize approved vaccinators to vaccinate using the Janssen vaccine as soon as they receive it from our federal partners.”

Though the new shot is easier to administer and requires only one dose, the administration is not altering its distribution plans. Zients says, “We’re distributing the J&J vaccine as we do the Moderna vaccine and the Pfizer vaccine.”

Dr. Anthony Fauci, the nation’s top infectious disease expert, and Dr. Marcella Nunez-Smith, the chair of the White House equity task force, encouraged Americans to take the first dose available to them, regardless of manufacturer.

Advisers to the Centers for Disease Control and Prevention voted overwhelmingly to recommend the vaccine for adults 18 years old and up. The ruling followed emergency clearance of the vaccine by U.S. regulators a day earlier.

Members of the group emphasized that all three vaccines now available in the U.S. are highly protective against the worst effects of the virus, including hospitalization and death.

Health officials are eager to have an easier-to-use vaccine against COVID-19, which has killed more than 511,000 Americans and continues to mutate in troubling ways.

CDC recommendations are not binding on state governments or doctors, but are widely heeded by the medical community. The same CDC panel previously recommended use of the two vaccines from Pfizer and Moderna authorized in December.

Popular

Latest

More News